Narrative review / 2020
Elevated serum erythritol predicts future central adiposity gain and type 2 diabetes mellitus in healthy adults.
This review summarizes recent findings on mammalian erythritol metabolism and its role as a predictive biomarker for cardiometabolic disease risk. Elevated serum erythritol predicts future central adiposity gain and type 2 diabetes mellitus in healthy adults. Erythritol is an endogenously synthesized product of glucose via the pentose phosphate pathway, with the final conversion catalyzed by sorbitol dehydrogenase and alcohol dehydrogenase 1. Additionally, dietary erythritol can be metabolized to erythrose or erythronate in humans before excretion, highlighting the need to evaluate the effects of long-term consumption.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Healthy adults and humans consuming dietary erythritol
- What was measured
- Future central adiposity gain, type 2 diabetes mellitus risk, and erythritol metabolism
THE PAPER
Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction.
Ortiz SR, Field MS. Curr Opin Clin Nutr Metab Care, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.